Showing results (101-110 of 131) with videos related to

Sort By:
Pageof 14
Bone Marrow Transplantation|August 22, 2018
The significance of peri-transplantation minimal residual disease assessed by multiparameter flow cytometry on outcomes for adult AML patients receiving haploidentical allograftsJing Liu, Rui Ma, Yan-Rong Liu, et al.
British Journal of Haematology|September 28, 2024
Mega-dose decitabine conditioning and prophylactic donor lymphocyte infusion for patients with relapsed/refractory AML with active disease at the time of allogeneic haematopoietic cell transplantation: A multicenter prospective phase II studyMeng Lv, Chen-Hua Yan, Rui Ma, et al.
BMC Cancer|June 17, 2020
Allogeneic hematopoietic stem cell transplantation can improve the prognosis of high-risk pediatric t(8;21) acute myeloid leukemia in first remission based on MRD-guided treatmentGuan-Hua Hu, Yi-Fei Cheng, Ai-Dong Lu, et al.
Cytotherapy|May 10, 2025
Incidence, risk factors and clinical outcomes of primary prolonged isolated thrombocytopenia following haploidentical transplantation for severe aplastic anemiaMing-Hao Lin, Wei Sun, Xiao-Jun Huang, et al.
Bone Marrow Transplantation|January 15, 2020
Impact of ABO incompatibility on outcomes after haploidentical hematopoietic stem cell transplantation for severe aplastic anemiaYan-Ru Ma, Wen-Jing Wang, Yi-Fei Cheng, et al.
British Journal of Haematology|November 6, 2021
Development and validation of a mortality predicting scoring system for severe aplastic anaemia patients receiving haploidentical allogeneic transplantationLan-Ping Xu, Yu Yu, Yi-Fei Cheng, et al.
Cytometry. Part B, Clinical Cytometry|August 20, 2019
The Quantification of Minimal Residual Disease Pre- and Post-Unmanipulated Haploidentical Allograft by Multiparameter Flow Cytometry in Pediatric Acute Lymphoblastic LeukemiaXin-Yu Wang, Qiao-Zhen Fan, Lan-Ping Xu, et al.
Chinese Medical Journal|December 5, 2018
Association of Persistent Minimal Residual Disease with Poor Outcomes of Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell TransplantationJing Liu, Xiao-Su Zhao, Yan-Rong Liu, et al.
American Journal of Hematology|January 26, 2019
Minimal residual disease status determined by multiparametric flow cytometry pretransplantation predicts the outcome of patients with ALL receiving unmanipulated haploidentical allograftsXiao-Su Zhao, Yan-Rong Liu, Lan-Ping Xu, et al.
Chinese Medical Journal|March 18, 2021
A risk score system for stratifying the risk of relapse in B cell acute lymphocytic leukemia patients after allogenic stem cell transplantationLe-Qing Cao, Yang Zhou, Yan-Rong Liu, et al.
Pageof 14